Cooper Companies reported its quarterly earnings results that surpassed analysts’ expectations.
The medical device company’s earnings came in at $3.24 a share for the quarter, above the Zacks’ consensus estimate of $3.10. The figure was $3.17 per share a year ago.
Cooper Companies revenue rose +15.7% from the year-ago quarter to $787.20 million, also exceeding analyst estimates of $739.30 million.
Looking ahead, Cooper expects its FY 2022 earnings in the range of $13.700-$14.200, and FY22 earnings of $13.70-$14.20 EPS.